More Post from the Author
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I
- La vacunacin materna contra el VRS reduce el riesgo de hospitalizacin infantil en ms del 80%
- ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
- CGTN: Ako kultrne vmeny podporuj nsko-vietnamsk priatestvo
- Milliken & Company verffentlicht Nachhaltigkeitsbericht 2025
HAVAS HEALTH NETWORK LAUNCHES ITS GLP-1 CONSULTANCY IN PARIS WITH "SHAPE SHIFTING" EVENT ON HEALTH AND WELLNESS
Published on Fri 7 Mar 2025 2:10:29 UTC
The network is bringing together thought leaders, branding experts, and healthcare professionals in their Paris Village to explore the latest transformational impact of GLP-1 treatments emerging and disrupting the European market.
PARIS, March 6, 2025 /PRNewswire/ -- Havas Health Network is launching its groundbreaking GLP-1 consultancy in Europe with flagship event, "Shape Shifting: A Close Look at the Health and Wellness Disruptor - GLP-1," on March 13th at the Havas Village in Paris.
Positioned at the nexus of health, creativity, and technology, this initiative underscores Havas' commitment to innovation, offering unique first mover thinking to clients, industry partners, and brand marketers navigating the rapidly growing GLP-1 space.
More Post from the Author
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I
- La vacunacin materna contra el VRS reduce el riesgo de hospitalizacin infantil en ms del 80%
- ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
- CGTN: Ako kultrne vmeny podporuj nsko-vietnamsk priatestvo
- Milliken & Company verffentlicht Nachhaltigkeitsbericht 2025